4D Molecular Therapeutics, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$5,411,438
16 notices · 429,637 sh
Oct 2025 to Oct 2026
Reported ·
$1,453,084
12 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
8 of 12 reported sales carry the 10b5-1 box.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-10-05David Kirn, See Remarks$753,662
2026-09-14David Kirn, See Remarks$802,662
2026-08-19David Kirn, See Remarks$1,157,714
2026-08-17SCOTT BIZILY, Chief Legal Officer$79,723
2026-08-13SCOTT BIZILY, Chief Legal Officer$19,407
2026-08-04David Kirn, See Remarks$275,399
2026-08-03David Kirn, See Remarks$125,267
2026-07-10David Kirn, See Remarks$193,575
2026-07-09David Kirn, See Remarks$549,217
2026-06-30SCOTT BIZILY, Chief Legal Officer$84,570
2026-06-23SCOTT BIZILY, Chief Legal Officer$102,220
Form 4, 2026-06-25: sold 9,810 at $12.00 Form 4 ↗
2026-06-22David Kirn, See Remarks$1,195,653
Form 4, 2026-06-23: sold 114,746 at $10.47 Form 4 ↗
2026-06-01David Kirn, See Remarks$18,663
Form 4, 2026-06-02: sold 1,922 at $10.02 Form 4 ↗
2025-12-16SCOTT BIZILY, Chief Legal Officer$17,903
Form 4, 2025-12-19: sold 1,635 at $10.90 Form 4 ↗
2025-11-17SCOTT BIZILY, Chief Legal Officer$17,642
Form 4, 2025-11-19: sold 1,635 at $10.59 Form 4 ↗